January 29, 1985 - Certificate of Need from the Missouri Health
Facilities Review Committee which created Midwest Stone Institute
was issued. The joint venture is a consortium of 13 hospitals
and initially over 50 urologists from the St. Louis area.
1985 through March 1986 - Dr. Peter Bub of Germany serves
as the first ESWL/Endourology fellow. Dr. Howard Winfield
served a fellowship under Ralph V. Clayman in Endourology
October 24, 1985 - The Dornier HM-3 lithotriptor was installed
and the first kidney stone lithotripsy was performed in Missouri
at Midwest Stone Institute.
October 25, 1985 - The original bylaws that brought Midwest
Stone Institute officially into being were signed.
February 1986 - An outpatient protocol for kidney stone lithotripsy
July 1986 - Midwest Stone Institute provides physician training
in ESWL as the first AUA certified site in Missouri.
December 1986 - Mallinckrodt Institute of Radiology secures
the right to investigate the second generation lithotriptor
known as the Siemens Lithostar and perform their first treatment.
This was the first Lithostar in the United States.
August 6, 1987 - The Missouri Health Facility Review Committee
approved the agreement between Midwest Stone Institute and
Mallinckrodt Institute of Radiology.
August 31, 1987 - Mallinckrodt Institute of Radiology signs
the agreement with Midwest Stone Institute under a Certificate
of Need ruling to enable Mallinckrodt to proceed with their
FDA trials under the auspices of Midwest Stone Institute’s
Certificate of Need. Midwest Stone Institute provides physician
support, administrative support, billing & scheduling
to the Lithostar at M.I.R..
June 1988 - Dr. Terri Monk does the first IV sedation treatment
on the HM-3 at MSI. Subsequently, all HM-3 procedures are
performed in this manner.
October 1988 - Siemens Lithostar, after IDE Trials through
a joint effort of Mallinckrodt Radiology and Midwest Stone
Institute, received FDA Approval.
August 1990 - The last month of treatment before Mallinckrodt
Institute of Radiology sold its Siemens Lithostar to a foreign
November 1990 - Midwest Stone Institute successfully adopts
the use of the Jenkins/Gillenwater (University of Virginia)
Stryker Frame adaptation for treatment of mid and lower ureteral
stone on the Dornier HM-3.
1991 - Midwest Stone Institute is approved as the first site
in the United States or Canada, for the FDA trials of the
June 3, 1992 - The Missouri Health Facilities Review Committee
CON granted a research exemption to Midwest Stone Institute
for studies on the EDAP LT-02 lithotriptor.
Mid-June 1992 - EDAP LT-02 arrived in the United States.
March 8, 1993 - The first patient was treated on the EDAP
March 1993 - Midwest Stone Institute received a determination
of non-reviewability from the Certificate of Need Committee
for our mobile lithotripsy project because it was below the
financial thresholds of the CON rules.
April 1993 - Midwest Stone Institute purchased a mobile Dornier
July 22, 1994 - The first Midwest Stone Institute mobile
lithotripsy was performed. The mobile HM-3 unit is home based
at Barnes Jewish West County Hospital.
1998 - Midwest Stone purchases a mobile LithoTron and Homium
August 1998 - Midwest Stone Institute begins participation
in the FDA trial using the OssaTron® shockwave technology
for musculoskeletal conditions
October 2000 - The FDA approves shockwave therapy for the
treatment of chronic proximal plantar fasciitis using the
March 12, 2002- FDA approves shockwave therapy for the treatment
of chronic lateral epicondylitis.
2003 - The FDA approves shockwave therapy for the treatment
of tennis elbow or lateral epicondylitis
2003 - Midwest Stone provides cryosurgery for the treatment
of prostate and kidney cancers as another minimally invasive
July, 2004- Midwest Stone Institute begins providing brachy
2006 MSI provides holmium ablation of the prostate services
To date over 12,000 patients have experienced the miracle
of ESWL and ESWT, through the auspices of Midwest Stone Institute.
In addition, Midwest Stone Institute has trained and certified
over 400 physicians to provide ESWL therapy under the permission
of the AUA training site committee. Lastly, since 1985, over
29 fellows in ESWL and Endourology have been supported and
trained by Midwest Stone Institute; many of these young urologists
have since taken posts in academic centers in the United States,
Germany, Canada, Israel and Austria.